BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Pluristem Therapeutics Issues Letter to Shareholders Highlighting Significant Achievements on Several Fronts

  October 9, 2012

   · 

  1 min read
• Business

  AngioDynamics Reports Fiscal 2013 First Quarter Financial Results

  October 9, 2012

   · 

  1 min read
• Cardionovum® Poised for Rapid Commercialization of Its Drug-Coated Balloons (DCB) and Drug-Eluting Stents (DES) in 57 Countries Outside of U.S.

  October 9, 2012

   · 

  1 min read
• Drug Development

  Interim Analysis Supports Continuation of Can-Fite BioPharma’s Phase 2/3 Psoriasis Clinical Study With CF101

  October 9, 2012

   · 

  3 min read
• Business

  Seattle Genetics, Inc. Achieves Milestones as Genentech Advances Two Antibody-Drug Conjugates (ADCs) Into Phase II Development

  October 9, 2012

   · 

  1 min read
• Medifocus Retains Consulting for Strategic Growth to Implement a Strategic Investor Relations & Public Relations Program

  October 9, 2012

   · 

  3 min read
• Business

  MedImmune Turns to New Avenues to Boost R&D

  October 9, 2012

   · 

  5 min read
• Business

  Merck & Co., Inc. Moves Global HQs to Cut Expenses, Consolidate Properties

  October 9, 2012

   · 

  1 min read
• Business

  LoneStar Heart, Inc. Grabs $20 Million for Lead Product to Treat Heart Failure

  October 9, 2012

   · 

  3 min read